In recent trading session, Dermata Therapeutics Inc (NASDAQ:DRMA) saw 1.23 million shares changing hands at last check today with its beta currently measuring 0.77. Company’s recent per share price level of $1.37 trading at $0.04 or 2.99% at last check today assigns it a market valuation of $2.07M. That most recent trading price of DRMA’s stock is at a discount of -967.15% from its 52-week high price of $14.62 and is indicating a premium of 10.95% from its 52-week low price of $1.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 87830.0 shares which gives us an average trading volume of 2.52 million if we extend that period to 3-months.
For Dermata Therapeutics Inc (DRMA), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -2.64 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dermata Therapeutics Inc (NASDAQ:DRMA) trade information
Upright in the green today for gaining 2.99%, in the last five days DRMA remained trading in the green while hitting it’s week-highest on Wednesday, 10/16/24 when the stock touched $1.37 price level, adding 8.67% to its value on the day. Dermata Therapeutics Inc’s shares saw a change of -85.03% in year-to-date performance and have moved 2.22% in past 5-day. Dermata Therapeutics Inc (NASDAQ:DRMA) showed a performance of -39.12% in past 30-days. Number of shares sold short was 69108.0 shares which calculate 0.05 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 77.17% to its recent value today. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -337.96% in reaching the projected high whereas dropping to the targeted low would mean a loss of -337.96% for stock’s current value.
Dermata Therapeutics Inc (NASDAQ:DRMA)’s Major holders
Insiders are in possession of 1.13% of company’s total shares while institution are holding 2.64 percent of that, with stock having share float percentage of 2.67%. Investors also watch the number of corporate investors in a company very closely, which is 2.64% institutions for Dermata Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Aug 31, 2024 , the former fund manager was holding 4.84 shares of worth $6677.0 or 0.32% of the total outstanding shares. The later fund manager was in possession of 66.0 shares on Aug 31, 2024 , making its stake of worth around $91.0 in the company or a holder of 0.00% of company’s stock.
